Moreover, Eskreis-Winkler and team pointed out that AI-directed MRI protocols can save valuable time. For example, they ...

Durvalumab is an IV drug that boosts the immune system’s ability to detect and kill cancer cells. It’s used to treat a range ...

Though some cancer patients lack sufficient enzymes to metabolize capecitabine or 5-FU, many patients are not warned about the risks associated with these treatments.

A newly developed molecular imaging technique can identify multiple subtypes of triple-negative breast cancer (TNBC), ...

The 59-year-old CEO of Sermo is running relentlessly in an effort to raise $1 million for stem cell transplant research.

From partnering with more health systems to testing a generative AI-powered health assistant, here are seven of Amazon’s healthcare moves reported by Becker’s since January: ...

Results from a new study help resolve the decade-long mystery of why many patients with the deadliest form of skin cancer do ...

This article is authored by Dr Robin Mendelsohn, MD, gastroenterologist, Memorial Sloan Kettering Cancer Center.

Person Event on June 5 led by FDA Commissioner Marty A. Makary, M.D., M.P.H. – LOS ANGELES, CA, June 06, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), ...

Home > Pressemitteilung: International Talents Gather in Jena: ...

These superfood powders are worth the hype!Protein powder is no longer the only thing you can add to your smoothie. Now ...

For patients with resectable gastric or gastroesophageal junction adenocarcinoma, durvalumab plus FLOT yields better outcomes than FLOT alone.